Rossari Biotech Q3 FY26 Results: Revenue Rises 13%; Stallion India to Consider Fundraising
Indian listed companies announced a series of corporate, financial, and governance updates, covering earnings performance, fundraising plans, compliance disclosures, and investor grievance status.
Rossari Biotech Ltd: Steady Q3 & 9M FY26 Performance Amid Soft Demand
Rossari Biotech Ltd presented its Q3 and 9M FY26 earnings, reporting healthy year-on-year growth despite a subdued domestic demand environment. For Q3 FY26, revenue from operations stood at ₹581.7 crore, marking a 13 percent YoY increase. EBITDA rose 7 percent YoY to ₹71.9 crore, while profit after tax increased 3 percent YoY to ₹36.9 crore. EBITDA margin came in at 12.3 percent, compared to 11.8 percent a year ago.
Core business segments, including HPPC, TSC, and AHN, delivered steady growth supported by diversified end-market exposure. The Institutional and B2C segments remained muted, though sequential losses reduced due to cost and portfolio rationalisation. Exports continued to support overall performance through focused growth in key geographies.
On the strategic front, Rossari received in-principle approval to set up specialty chemicals manufacturing facilities in Saudi Arabia through a wholly owned subsidiary, aimed at strengthening supply chain resilience and improving speed-to-market. The company continues phased capacity expansion across verticals, with management expressing confidence that operating leverage and scale benefits will support margin improvement over time.
Stallion India Fluorochemicals Ltd: Board to Consider Capital Raise
Stallion India Fluorochemicals Ltd announced that its Board of Directors will meet on January 21, 2026, to consider fundraising through equity shares or other securities, including a potential rights issue. The trading window for the company’s securities will remain closed from the date of intimation until 48 hours after the board meeting outcome is disclosed.
Inspirisys Solutions Ltd: Statutory Auditor Constitution Change
Inspirisys Solutions Ltd informed exchanges of a change in the constitution of its statutory auditor. M/s MSKA & Associates has converted from a partnership firm into a Limited Liability Partnership, now named MSKA & Associates LLP, effective January 13, 2026. The company clarified that this change does not impact the auditor’s role, and the LLP will continue as statutory auditor for the remainder of its tenure.
Cube Highways Trust InvIT: No Investor Grievances Reported
Cube Highways Trust InvIT reported that no investor complaints were received, disposed of, or pending during the quarter ended December 31, 2025, as well as for the FY26 year-to-date period, indicating a smooth operational phase with respect to investor grievance redressal.
Overall, the disclosures reflect stable earnings performance, continued strategic investments, orderly governance actions, and compliance transparency across the listed entities.
